Fingerprint
Dive into the research topics of 'Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
E. Gabriela Chiorean, Daniel D. Von Hoff, Josep Tabernero, Robert El-Maraghi, Wen Wee Ma, Michele Reni, Marion Harris, Robert Whorf, Helen Liu, Jack Shiansong Li, Victoria Manax, Alfredo Romano, Brian Lu, David Goldstein
Research output: Contribution to journal › Article › peer-review
53
Scopus
citations